Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
OTC Drugs

Study Provides "Reassurance" That Sunscreen Use Reduces Melanoma Risk

This article was originally published in The Tan Sheet

  • News
  • Mary Ann Moon

Executive Summary

Regular sunscreen use can help prevent melanoma, the most serious form of skin cancer, suggests a study published in the Journal of Clinical Oncology.

You may also be interested in...



Study Provides "Reassurance" That Sunscreen Use Reduces Melanoma Risk

Regular sunscreen use can help prevent melanoma, the most serious form of skin cancer, suggests a study published in the Journal of Clinical Oncology.

Study Provides "Reassurance" That Sunscreen Use Reduces Melanoma Risk

Regular sunscreen use can help prevent melanoma, the most serious form of skin cancer, suggests a study published online Dec. 6 in the Journal of Clinical Oncology.

Nicotine Patch Plus Lozenge Tops GSK Cessation Options - Study

Using an OTC nicotine patch in conjunction with lozenges appears to be the most effective approach GlaxoSmithKline offers for smoking cessation, according to a study that included OTC products, the active ingredient in Wellbutrin and various combinations

Table

View full table

Topics

Tags:
OTC Drugs
Latest Headlines

Partisan Politics Returns To US FDA Congressional Oversight

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

See All
UsernamePublicRestriction

Register

PS104778

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By